Motor complications in an incident Parkinson’s disease cohort

N. W. Scott, A. D. MacLeod (Corresponding Author), C. E. Counsell

Research output: Contribution to journalArticle

28 Citations (Scopus)
8 Downloads (Pure)

Abstract

Background and purpose
Levodopa treatment in Parkinson's disease (PD) causes motor fluctuations and dyskinesias, but few data describe their development or severity in unselected incident cohorts.

Methods
Demographic, clinical, treatment, smoking, caffeine and alcohol data from 183 people with PD were gathered from the Parkinsonism Incidence in Northeast Scotland (PINE) study, a community-based, incident cohort. With Kaplan–Meier survival analysis and Cox regression modelling the development, and severity, of dyskinesias and motor fluctuations and which factors independently influenced their onset were assessed.

Results
After a mean follow-up of 59 months, 39 patients (21.3%) developed motor fluctuations and 52 (28.4%) developed dyskinesias. Kaplan–Meier estimates of the probability of motor fluctuations and dyskinesias after 5 years of dopaminergic treatment were 29.2% [95% confidence interval (CI) 21.5%–38.8%] and 37.0% (95% CI 28.5%–47.1%) respectively. 19.8% developed motor fluctuations requiring treatment changes but only 4.0% (95% CI 1.5%–10.4%) developed dyskinesias requiring treatment changes by 5 years. Cumulative levodopa dose [hazard ratio (HR) 1.38 (95% CI 1.19–1.60)], female sex [HR 2.41 (1.19–4.89)] and younger age at diagnosis [HR 1.08 (1.04–1.11)] were independently associated with development of motor fluctuations. Cumulative levodopa dose [HR 1.23 (1.08–1.40)] and female sex [HR 2.51 (1.40–4.51)] were independently associated with dyskinesias. In exploratory analyses, moderate caffeine exposure was associated with fewer motor fluctuations, longer symptom duration with more dyskinesias, and tremor at diagnosis with higher rates of both complications.

Conclusions
In this community-based incident PD cohort, severe dyskinesias were rare. Cumulative levodopa dose was the strongest predictor of both dyskinesias and motor fluctuations.
Original languageEnglish
Pages (from-to)304-312
Number of pages9
JournalEuropean Journal of Neurology
Volume23
Issue number2
Early online date13 Jun 2015
DOIs
Publication statusPublished - Feb 2016

    Fingerprint

Keywords

  • Parkinson's disease
  • motor fluctuations
  • dyskinesias
  • motor complications
  • levodopa

Cite this